Severe Dermatitis Tied to Dupilumab-Associated Conjunctivitis Severe Dermatitis Tied to Dupilumab-Associated Conjunctivitis
Severe disease at baseline may be one of the factors associated with the development of conjunctivitis following treatment of atopic dermatitis with dupilumab, according to a small retrospective study.Reuters Health Information
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Dermatology News Source Type: news
More News: Allergy | Allergy & Immunology | Conjunctivitis | Dermatitis | Dermatology | Skin | Study